日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Skeletal muscle and MASLD: Mechanistic and clinical insights

骨骼肌与MASLD:机制和临床见解

Marjot, Thomas; Armstrong, Matthew J; Stine, Jonathan G

Dose-dependent and tissue-specific adverse effects of exogenous glucocorticoids: insights for optimizing clinical practice

外源性糖皮质激素的剂量依赖性和组织特异性不良反应:优化临床实践的启示

Pofi, Riccardo; Othonos, Nantia; Marjot, Thomas; Bonaventura, Ilaria; Barrett, Amy; White, Sarah; Miller, Hamish; Potter, Tom; Bailey, Maíra; Eastell, Richard; Gossiel, Fatma; Woods, Conor; Hazlehurst, Jonathan M; Hodson, Leanne; Tomlinson, Jeremy W

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

SARS-CoV-2疫苗接种对血管性肝病患者的影响:一项VALDIG多中心研究的观察结果

Perez-Campuzano, Valeria; Rautou, Pierre-Emmanuel; Marjot, Thomas; Praktiknjo, Michael; Alvarado-Tapias, Edilmar; Turco, Laura; Ibáñez-Samaniego, Luis; González-Alayón, Carlos; Puente, Ángela; Llop, Elba; Simón-Talero, Macarena; Álvarez-Navascués, Carmen; Reiberger, Thomas; Verhelst, Xavier; Tellez, Luis; Bergmann, Johanna Birte; Orts, Lara; Grassi, Giuseppe; Baiges, Anna; Audrey, Payance; Trebicka, Jonel; Villanueva, Candid; Morelli, Maria Cristina; Murray, Sam; Meacham, Georgina; Luetgehetmann, Marc; Schulze Zur Wiesch, Julian; García-Pagán, Juan-Carlos; Barnes, Eleanor; Plessier, Aurélie; Hernández-Gea, Virginia

Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans

人类肝脏脂肪含量与选择性肝脏胰岛素抵抗的空腹代谢标志物之间的分离

Westcott, Felix A; Nagarajan, Shilpa R; Parry, Sion A; Savic, Dragana; Green, Charlotte J; Marjot, Thomas; Johnson, Elspeth; Cornfield, Thomas; Mózes, Ferenc E; O'Rourke, Paige; Mendall, Jessica; Dearlove, David; Fielding, Barbara; Smith, Kieran; Tomlinson, Jeremy W; Hodson, Leanne

Shift work and evening chronotype are associated with hepatic fat fraction and non-alcoholic fatty liver disease in 282,303 UK biobank participants

在英国生物银行的282,303名参与者中,轮班工作和晚睡晚起的作息类型与肝脏脂肪含量和非酒精性脂肪肝疾病相关。

Maidstone, Robert; Rutter, Martin K; Marjot, Thomas; Ray, David W; Baxter, Matthew

Evaluating Disparities in COVID-19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe-An International Registry Study

评估北美和欧洲肝硬化患者 COVID-19 临床结局差异——一项国际注册研究

Hayat, Umar; Moon, Andrew M; Gangwani, Manesh K; Hasan, Fariha; Marjot, Thomas; Barritt, A Sidney 4th; Mirza, Wasique; Deivert, Duane; Aziz, Muhammad; Dahiya, Dushyant Singh; Ali, Hassam; Inamdar, Sumant; Garcia-Saenz-de-Sicilia, Mauricio

Recruitment, Retention, and Training of Citizen Scientists in Translational Medicine Research: A Citizen Science Initiative on Non-Alcoholic Fatty Liver Disease

公民科学家在转化医学研究中的招募、留任和培训:一项关于非酒精性脂肪肝疾病的公民科学计划

Shah, Syed Ghulam Sarwar; Barrado-Martín, Yolanda; Marjot, Thomas; Tomlinson, Jeremy W; Kiparoglou, Vasiliki

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

在一项概念验证性随机双盲安慰剂对照试验中,11β-HSD1抑制剂可减轻男性服用泼尼松龙引起的副作用。

Othonos, Nantia; Pofi, Riccardo; Arvaniti, Anastasia; White, Sarah; Bonaventura, Ilaria; Nikolaou, Nikolaos; Moolla, Ahmad; Marjot, Thomas; Stimson, Roland H; van Beek, André P; van Faassen, Martijn; Isidori, Andrea M; Bateman, Elizabeth; Sadler, Ross; Karpe, Fredrik; Stewart, Paul M; Webster, Craig; Duffy, Joanne; Eastell, Richard; Gossiel, Fatma; Cornfield, Thomas; Hodson, Leanne; Jane Escott, K; Whittaker, Andrew; Kirik, Ufuk; Coleman, Ruth L; Scott, Charles A B; Milton, Joanne E; Agbaje, Olorunsola; Holman, Rury R; Tomlinson, Jeremy W

Circadian regulation of liver metabolism: experimental approaches in human, rodent, and cellular models

肝脏代谢的昼夜节律调控:人类、啮齿动物和细胞模型中的实验方法

Daniels, Lorna J; Kay, Danielle; Marjot, Thomas; Hodson, Leanne; Ray, David W

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes

SARS-CoV-2感染与肝脏疾病:发病机制和预后综述

Baldelli, Luke; Marjot, Thomas; Barnes, Eleanor; Barritt, A Sidney; Webb, Gwilym J; Moon, Andrew M